Spectral Diagnostics (OTCMKTS:EDTXF) Stock Price Down 1.5% – Here’s What Happened

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) shares fell 1.5% on Friday . The stock traded as low as $0.9026 and last traded at $0.9378. 119,246 shares changed hands during trading, an increase of 1,464% from the average session volume of 7,627 shares. The stock had previously closed at $0.9520.

Spectral Diagnostics Trading Down 1.5%

The firm’s 50-day moving average price is $1.00 and its 200 day moving average price is $0.88. The company has a market capitalization of $271.17 million, a price-to-earnings ratio of -8.53 and a beta of 0.09.

Spectral Diagnostics (OTCMKTS:EDTXF) last released its earnings results on Friday, November 7th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.07). The business had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.54 million.

Spectral Diagnostics Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.